Therapies
Friday, November 9th, 2012
Popular Mechanics: 11/1/12 Every year nearly 800,000 Americans suffer a stroke. Eighty-five percent of the survivors end up having some degree of hand disability as a result. After leaving the hospital, the majority of a stroke patient’s rehabilitation consists of repetitive at-home exercises, says Nizan Friedman, a biomedical engineering student at the University of California, Irvine. “The […]
Therapies
Friday, November 9th, 2012
Wiley: 10/25/12 Dabigatran is an oral direct thrombin inhibitor recently approved for stroke prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of dabigatran are freedom from monitoring and less interaction with other drugs and food. It is ideal for patients who are unwilling to adhere to regular coagulation monitoring or whose […]
Therapies
Monday, November 5th, 2012
Neurology.org: 10/31/12 To evaluate the relationship between antihypertensive (AH) drug adherence and cardiovascular (CV) outcomes among patients with a recent ischemic stroke and assess the validity of our approach. Methods: A cohort of 14,227 patients diagnosed with an ischemic stroke was assembled from individuals 65 years and older who were treated with AH agents from 1999 to […]
Therapies
Monday, November 5th, 2012
Society of NeuroInterventional Surgery: 10/31/12 Background and aim During endovascular procedures for acute ischemic stroke, catheter access to the occluded vessel may be technically difficult or impossible. The aim of this study was to access the impact of difficult catheter access to target the carotid artery on clinical outcome. Methods Anterior circulation stroke patients undergoing transfemoral endovascular procedures […]
Therapies
Monday, November 5th, 2012
Plosone: 10/31/12 Individuals with TIA/stroke symptoms often do not seek urgent medical attention. We assessed the feasibility of identifying individuals searching for information on TIA/stroke symptoms online as a target for future interventions to encourage urgent evaluation and we evaluated the performance of a self-reported risk score to identify subjects with true TIA or stroke. Methodology/Principal […]
Therapies
Thursday, October 25th, 2012
Stroke AHA Journals: October 23, 2012 Unclear-onset strokes are generally excluded from time-based thrombolytic therapy. We examined the safety and feasibility of magnetic resonance imaging-based reperfusion therapy in unclear-onset stroke. Methods—This prospective, multicenter, single-arm study screened consecutive unclear-onset stroke patients within 6 hours of symptom detection. Patients with perfusion-diffusion mismatch >20% and negative or subtle fluid-attenuated […]
Therapies
Thursday, October 25th, 2012
Stroke AHA Journals: September 20, 2012 A Systematic Review and Meta-Analysis of 55 Studies Recombinant tissue plasminogen activator (rtPA) is an effective treatment for acute ischemic stroke but is associated with an increased risk of intracranial hemorrhage (ICH). We sought to identify the risk factors for ICH with a systematic review of the published literature. Methods—We […]
Therapies
Thursday, October 25th, 2012
Stroke AHA Journals: September 13, 2012 Summary of a Cochrane Systematic Review and Meta-Analysis Stroke is a major cause of morbidity and mortality worldwide. One of the major complications in the acute phase of stroke is infection; especially pneumonia and urinary tract infection occur often. Poststroke infections are strongly associated with poor outcome. Preventive antibiotic therapy […]
Therapies
Thursday, October 25th, 2012
Stroke AHA Journals: September 13, 2012 Poststroke spasticity (PSS) is a common complication associated with other signs and symptoms of the upper motor neuron syndrome, including agonist/antagonist co-contraction, weakness, and lack of coordination. Together, they result in impairments and functional problems that can predispose to costly complications. The goal of PSS management should take into consideration […]
Therapies
Thursday, October 25th, 2012
Stroke AHA Journals: August 30, 2012 Dementia has become a pressing health issue, with numbers steadily increasing. Vascular injury is the second most common cause of dementia after Alzheimer disease (AD) and a defining feature of vascular cognitive impairment (VCI), which encompasses the full range from vascular dementia (VaD) to mild cognitive impairment of vascular origin.1,2 […]